Prognostic Markers for Metastatic Colorectal Cancer Response to TAS-102 Treatment
- *Abstract
-
- *Stage of Development
- Tested in a large testing cohort ofmetastatic colorectal cancer patientsAvailable for exclusive ornon-exclusive license
- Country/Region
- USA
For more information, please click Here

